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SUMMARY:  20 
This protocol describes a set of methods to identify the cell-type specific functional connectivity 21 
of long-range inputs from distant brain regions using optogenetic stimulations in ex vivo brain 22 
slices.  23 
 24 
ABSTRACT:  25 
Knowledge of cell-type specific synaptic connectivity is a crucial prerequisite for understanding 26 
brain-wide neuronal circuits. The functional investigation of long-range connections requires 27 
targeted recordings of single neurons combined with the specific stimulation of identified distant 28 
inputs. This is often difficult to achieve with conventional and electrical stimulation techniques, 29 
because axons from converging upstream brain areas may intermingle in the target region. The 30 
stereotaxic targeting of a specific brain region for virus-mediated expression of light-sensitive ion 31 
channels allows selective stimulation of axons originating from that region with light. 32 
Intracerebral stereotaxic injections can be used in well-delimited structures, such as the anterior 33 
thalamic nuclei, in addition to other subcortical or cortical areas throughout the brain. 34 
 35 
Described here is a set of techniques for precise stereotaxic injection of viral vectors expressing 36 
channelrhodopsin in the mouse brain, followed by photostimulation of axon terminals in the 37 
brain slice preparation. These protocols are simple and widely applicable. In combination with 38 
whole-cell patch clamp recording from a postsynaptically connected neuron, photostimulation 39 
of axons allows the detection of functional synaptic connections, pharmacological 40 
characterization, and evaluation of their strength. In addition, biocytin filling of the recorded 41 
neuron can be used for post-hoc morphological identification of the postsynaptic neuron.  42 
 43 
INTRODUCTION:  44 
 
  
 
Defining connectivity between brain regions is necessary to understand neural circuits. Classical 45 
anatomical tracing methods allow establishing interregional connectivity, and lesion studies help 46 
to understand the hierarchical organization of information flow. For example, brain circuits for 47 
spatial orientation and head direction signaling involve the directional flow of information from 48 
the thalamus to the presubiculum. This has been demonstrated by lesion studies of antero-dorsal 49 
thalamic nuclei (ADN) that degrade the head direction signal in the downstream dorsal 50 
presubiculum, as well as the parahippocampal grid cell signal1,2. 51 
 52 
The functional connectivity between brain areas is more difficult to establish at a cellular and 53 
subcellular level. In the hippocampus, a highly organized anatomy allows to investigate pathway-54 
specific synaptic connections using electrical simulation in the slice preparation. Stimulation 55 
electrodes placed in stratum radiatum of CA1 can be used to specifically stimulate Schaffer 56 
collateral input from CA33. Stimulating electrodes placed in stratum lacunosum moleculare of 57 
CA1 will activate the perforant path input to CA14,5. Electrical stimulation activates 58 
neurotransmitter release from axon terminals; however, it activates neurons with somata near 59 
the stimulation site as well as axons of passage. It is therefore of limited use for studying afferents 60 
from defined brain regions when fibers of different regions of origin intermingle in the target 61 
structure, as is typically the case in the neocortex.  62 
 63 
Neurons may also be stimulated with light. Optical methods include the photoactivation of caged 64 
glutamate, which can be combined with one- or two-photon laser scanning. Multiple closely 65 
spaced sites may be stimulated sequentially, with no mechanical damage to the tissue6. This has 66 
been successfully used to map synaptic receptors as well as activate individual neurons7. While 67 
glutamate uncaging can be used for local circuit analysis, it does not allow for specific activation 68 
of long-range inputs.  69 
 70 
A method of choice for the investigation of long-range connectivity in neuronal circuits is the use 71 
of virus-mediated channelrhodopsin expression. Using in vivo stereotaxic injections as described 72 
here, the expression of light-gated ion channels can be targeted and spatially restricted to a 73 
desired brain region. In this way, channelrhodopsins are effective for mapping excitatory or 74 
inhibitory connectivity from one region to its target. Transfected axons terminals may be 75 
stimulated with light in a brain slice preparation, and patch-clamp recordings as a read-out allow 76 
examination of the functions and strengths of specific circuit components in the brain8. The 77 
optogenetic approach combined with stereotaxic injection of a virus offers unprecedented 78 
specificity and genetic control9. Stimulating with light additionally allows for both high temporal 79 
and spatial precision10,11.  80 
 81 
The presubiculum is a six-layered cortical structure at the transition of the hippocampus and the 82 
para-hippocampal formation12,13. It receives important synaptic input from the ADN11 but also 83 
from several other cortical and subcortical regions14. Thus, the selective stimulation of thalamic 84 
axons terminals within a presubicular slice is not possible with electrical stimulation nor 85 
glutamate uncaging. Described in this protocol are methods to determine functional connectivity 86 
between brain regions (ADN and presubiculum) using precise stereotaxic injections of viral 87 
vectors expressing light-gated channels. Also described is the photostimulation of axons 88 
 
  
 
terminals of projecting neurons in their target region, coupled with whole-cell patch-clamp 89 
recordings of post-synaptic neurons in the brain slice preparation. 90 
 91 
PROTOCOL: 92 
All procedures were performed in accordance with the European Community Council Directive 93 
(2010/63/EU) and approved by the ethics committee of Paris Descartes University. The 94 
experimenter must obtain authorization for the procedure to comply with local regulations.  95 
 96 
1. Planning of the experiment 97 
 98 
1.1. Define the brain area to be targeted. Determine the stereotaxic coordinates of the injection 99 
site with the help of a mouse brain atlas15. For the right antero-dorsal thalamic nucleus (ADN), 100 
the coordinates are: -0.82 posterior, 0.75 lateral, -3.2 depth (mm) relative to bregma. 101 
Coordinates may need to be adjusted for animals of different age, sex, or strain.  102 
 103 
1.2. Confirm and document the exactitude of the coordinates by injecting a fluorescent tracer 104 
(150 to 300 nL) observable with an epifluorescence microscope in a pilot experiment (Figure 105 
1A,B).  106 
 107 
1.3. Define the type of virus to be injected. Store the virus in 6 µL aliquots at -80 °C as 108 
recommended by the producer. Bring 1 aliquot placed on ice to the surgery room, for injection 109 
of one to six animals on a given day. Biosafety regulations for the use of AAV may depend on the 110 
country or institution, and the use of a PSM 2 hood may be required.  111 
 112 
NOTE: Here, we use a AAV2/5 serotype expressing Chronos, a fast channelrhodospin-2 variant, 113 
fused to green fluorescent protein under the control of the Synapsin promoter: 114 
AAV5.Syn.Chronos-GFP.WPRE.bGH.  115 
 116 
2. Stereotaxic surgery 117 
 118 
2.1. Install a stereotaxic frame equipped with a pump holder on a stable standard laboratory 119 
bench. Adjust stereoscope so as to clearly see the zone where the animal’s head will be placed. 120 
Use a LED light source for illumination. Rotate the stereoscope away to access the pump holder, 121 
which is not needed for the first steps of the surgery. 122 
 123 
2.2. Install a 10 µL Hamilton syringe equipped with a 33 G beveled metal needle in the pump 124 
holder. Test the ejection system with water. 125 
 126 
2.3. Anesthetize a 4- to 5-week old C57BL6 mouse with an intraperitoneal injection of a mix of 127 
ketamine hydrochloride and xylazine (100 mg/kg and 10 mg/kg, respectively). Prepare a mix of 1 128 
mL of ketamine and 0.5 mL of xylazine in 8.5 mL of 0.9% NaCl. This will result in 10 mg/mL 129 
ketamine and 1 mg/mL xylazine in the mix. Of this mix, inject intraperitoneally 10 µL per gram of 130 
the animal’s body weight. Duration of anesthesia is about 1 h. 131 
 132 
 
  
 
2.4. Verify that the animal is well-anesthetized with a toe pinch. Then, pull out the tongue to 133 
facilitate breathing. Shave the cranial hair.  134 
 135 
2.5. Inject 20 µL of lidocaine hydrochloride (4 mg/mL; 2 mg/kg) under the skin of the head for 136 
local anesthesia and wait 5 min for the effect to begin. To avoid eye damage due to dryness, 137 
cover the eyes with topical ophthalmic ointment. 138 
 139 
2.6. To expose the skull, create a straight cut in the scalp with small surgery scissors. Place the 140 
animal in a stereotaxic frame, inserting the ear bars slightly rostral to the actual ear to rest on 141 
the bone and pull down the skin, which should create good access to the skull. Tighten into place. 142 
Install the nose piece. 143 
 144 
2.7. Maintain the body of the animal horizontally at the level of the head using a height-adjusted 145 
support. Place a heating pad under the mouse to keep it at physiological temperature.  146 
 147 
2.8. Clean the skull by applying 0.9% NaCl with a cotton swab to remove soft tissue from the 148 
bone. Use the stereoscope for the rest of the surgery. 149 
 150 
2.9. Adjust the skull so that the bregma-lambda axis is level, moving up or down the nose and 151 
teeth piece. This necessitates iterative measures of bregma and lamba, as both will change 152 
following adjustment of the nose level. 153 
 154 
2.10. Find the location of the injection site on the skull. Adjust the injection needle above the 155 
injection site according to posterior and medial coordinates and mark the skull with a disposable 156 
needle. Move the injection needle upward by 4 cm. 157 
 158 
2.11. Use a 0.5 mm burr with a drill to realize a 1 mm diameter craniotomy on the mark, at one-159 
half of maximum speed. Swab eventual bleeding with a paper tissue.  160 
 161 
2.12. Empty the water contained in the Hamilton syringe for storage by completely ejecting it 162 
with the pump. Only the needle will still be filled with water. 163 
 164 
2.13. Take the centrifuge tube with the aliquot of virus that is to be used for this day. Make sure 165 
that the viral solution is not frozen anymore but has remained cooled (close to 0 °C, on ice). OnLy 166 
briefly remove from the ice to obtain 700 nL with a micropipette for small volumes. Deposit the 167 
drop on a 5 cm x 5 cm piece of paraffin film. Avoid creating bubbles. Put the remaining viral 168 
solution back on ice. 169 
 170 
NOTE: The drop volume should be greater than the desired injection volume (700 nL for 200 nL 171 
injected). This will give a safety margin in case some of the liquid is lost during the transfer and 172 
allows performing a small test ejection (step 2.16) before proceeding.  173 
 174 
2.14. Place the paraffin film on top of the craniotomy. Plunge the needle in the drop of viral 175 
solution without changing the antero-posterior and lateral position.  176 
 
  
 
 177 
2.15. Use the “withdraw” function of the pump to fill the syringe with about 500 nL of viral 178 
solution disposed on the paraffin film.  Do this under visual control (stereoscope), watch the drop 179 
disappear, and make sure not to aspirate air.  180 
 181 
2.16. Make sure the syringe has been filled correctly. Verify the functioning of the ejection 182 
system by driving down the plunger to test eject a small drop of liquid of 50 nL under visual 183 
control. Wipe the drop. 184 
 185 
2.17. Insert the needle into the brain to the chosen depth, by turning the knob controlling the 186 
dorso-ventral axis of the stereotaxic apparatus clockwise. Push the “run” button (speed 15 187 
nL/min per volume of 150 nL injected). A small volume (50–300 nL, depending on the virus used) 188 
is slowly ejected over 10 min with an automatic pump.  189 
 190 
2.18. Wait 10 min after the injection to avoid leaking from the injection site. Then, slowly remove 191 
the needle over 3–5 min by turning the knob controlling the dorso-ventral axis counterclockwise.   192 
 193 
2.19. Rotate the vertical part of the stereotaxic frame with the syringe away from the animal. 194 
Immediately wash the needle in clean distilled water by filling-emptying it several times, in order 195 
to avoid clogging. Store the syringe filled with water. 196 
 197 
2.20. Remove the mouse from the stereotaxic frame. Suture the skin with 4-0 polyamide suture 198 
filament. Make three or four stiches, tied with 2-1-1 standard surgical knots. 199 
 200 
2.21. Place the mouse in a heated cage until it completely wakes up from anesthesia, and provide 201 
water and soaked food in a Petri dish placed on the ground. If the heat source is below the cage, 202 
use a spacer grid to avoid overheating.   203 
 204 
NOTE: According to local guidelines, a single dose of ketoprofen (2–5 mg/kg, subcutaneously) or 205 
buprenorphine (0.05–0.1 mg/kg, subcutaneously) may be applied to prevent pain.  206 
 207 
2.22. When the animal is fully awake, return it to its home cage and monitor its well-being, 208 
particularly on the day following injection. Check for signs of pain. If any behavioral modification 209 
is observed, the animal is weighed to monitor its body weight. 210 
 211 
2.23. Depending on the virus used, the time for full expression may vary. Here, we allow 3 weeks 212 
for expression of AAV5.Syn.Chronos-GFP. 213 
 214 
3. Solutions for acute slice recordings and fixation  215 
 216 
3.1. Prepare stock solutions of 10x concentrated cutting solution (125 mM NaCl, 25 mM sucrose, 217 
2.5 mM KCl, 25 mM NaHCO3, 1.25 mM NaH2PO4, and 2.5 mM D-glucose) and artificial 218 
cerebrospinal fluid (ACSF) solution (124 mM NaCl, 2.5 mM KCl, 26 mM NaHCO3, 1 mM NaH2PO4, 219 
and 11 mM D-glucose) in pure deionized water prior to electrophysiology experiments. Store 220 
 
  
 
these solutions at 4 °C in 1 L bottles without CaCl2 and MgCl2.  221 
 222 
3.2. On the day of the experiment, dilute the stock solutions of cutting solution and ACSF 10x to 223 
a final volume of 0.5 L each. Agitate with a magnetic stirrer and oxygenize by bubbling with 224 
95%/5% O2/CO2. Add divalent ions to obtain final concentrations of 0.1 mM CaCl2 and 7 mM 225 
MgCl2 for the cutting solution, and 2 mM CaCl2 and 2 mM MgCl2 for ACSF. 226 
 227 
3.3. Prepare the potassium-gluconate based pipette solution to contain: 135 mM K-gluconate, 228 
1.2 mM KCl, 10 mM HEPES, 0.2 mM EGTA, 2 mM MgCl2, 4 mM MgATP, 0.4 mM Tris-GTP, 10 mM 229 
Na2-phosphocreatine, and 2.7–7.1 mM biocytin for post-hoc cell morphology revelation. Adjust 230 
the solution’s pH to 7.3 and osmolarity to 290 mOsm. Store 1 mL aliquots at -20 °C. 231 
 232 
3.4. Prepare 0.1 M PBS by diluting BupH PBS dry-blend powder pouches in 500 mL of distilled 233 
water, resulting in 0.1 M sodium phosphate, 0.15 M NaCl, pH 7.2. 234 
 235 
3.5. To prepare 1 L of 4% PFA solution, dilute 111 mL of 36% liquid PFA and 90 mL of 10x PBS 236 
solution in distilled water. 237 
 238 
3.6. Prepare 30% sucrose solution containing 150 g of sucrose in 500 mL of 0.1 M PBS. 239 
 240 
4. Preparation of brain slices 241 
 242 
4.1. Prepare the bench space with absorbent bench paper before perfusion.  243 
 244 
4.2. Install a drip about 1 m above the bench for gravity-fed perfusion. Attach a 24 G butterfly 245 
needle. 246 
 247 
4.3. Surround the cutting chamber of the vibratome with ice and store it in a freezer. 248 
 249 
4.4. Anesthetize the mouse with intraperitoneal injection of the same ketamine-xylazine mixture 250 
used for surgery. Assess the stage of the anesthesia by pinching the toe with forceps. When fully 251 
asleep, inject 100 µL of heparin (5000 U.I./mL) intraperitoneally.  252 
 253 
4.5. Fix the animal with adhesive tape on the absorbent paper, lying on its back. Open the 254 
thoracic cage by cutting the ribs on the left and right sides with small scissors, from the diaphragm 255 
upwards. Maintain the thoracic cage open with the help of adhesive tape.  256 
 257 
4.6. Clamp the descending aorta with a hemostat and perfuse via the left ventricle of the heart 258 
with 4 °C cooled and oxygenated (95%/5% O2/CO2), cutting the solution through the 24 G 259 
butterfly needle. After 5 s, open the right atrium with small scissors. 260 
 261 
4.7. After 5 min of perfusion, when the organs are bloodless, stop the perfusion. Decapitate the 262 
animal with big scissors and immerge the head into 4 °C cooled and oxygenated cutting solution 263 
in a Petri dish.  264 
 
  
 
 265 
4.8. To extract the brain, cut the skin from neck to nose, then section the last vertebrae from the 266 
skull with scissors. Manually retract the skin and use small scissors to open the skull, cutting it 267 
along the midline, from caudal to rostral, upward to between the eyes.  268 
 269 
4.9. Carefully remove the parietal bone and caudal part of frontal bone with curved or bone 270 
forceps. Extract the brain with a small rounded spatula by inserting the instrument between the 271 
brain and the cranial floor, sectioning the olfactory bulb, optic nerve and other cranial nerves, 272 
and cerebellum. 273 
 274 
4.10. Gently submerge the brain in ice-cold cutting solution (4 °C) in a beaker. Position the brain 275 
on filter paper to gently dry the cortical surface. Glue the brain cortex-down to the specimen 276 
holder of a vibratome, with the caudal side facing the blade, in order to cut horizontal brain slices. 277 
 278 
4.11. Fill the cutting chamber with ice-cold oxygenated cutting solution so the brain is fully 279 
immerged. Make a cut on the left hemisphere (contralateral to the injected side) to avoid 280 
potential left-right ambiguity on slices.  281 
 282 
CAUTION: Always oxygenate the solution and protect slices from light exposure. 283 
 284 
4.12. Cut 300 µm thick slices with the vibratome, at a speed of 0.07 mm/s at 1 mm amplitude. At 285 
this stage, it is recommended to briefly check the Chronos-GFP expression in the thalamus using 286 
a fluorescent flashlight (440–460 nm) and corresponding filter glasses (500 nm long pass). 287 
 288 
4.13. Isolate the hippocampal region with a scalpel and transfer it to a chamber positioned in a 289 
beaker filled with bath-warmed (34 °C), oxygenated (95%/5% O2/CO2) ACSF.  290 
 291 
4.14. After 15 min, take the chamber out of the heated water bath and let the slices rest at room 292 
temperature, still oxygenated for at least 45 min until use. 293 
 294 
5. Whole-cell patch-clamp recording 295 
 296 
5.1. Gently transfer a brain slice containing the hippocampal complex with a custom-made glass 297 
transfer pipette to the recording chamber mounted on an upright microscope. A transfer pipette 298 
is made of a shortened Pasteur pipette (inner diameter 6.5 mm) attached to a rubber pipette 299 
bulb. Continuously perfuse the recording chamber (3 mL) with 34 °C (warmed) ACSF bubbled with 300 
95%/5% O2/CO2. Set the speed of the peristaltic pump to 2–3 mL/min. 301 
 302 
5.2. Briefly examine Chronos-GFP expression in axon terminals in the region of interest with blue 303 
LED illumination (470 nm) and observe with a 4x objective. GFP fluorescence is visualized through 304 
an appropriate emission filter, with a CCD camera image displayed on a computer screen.  305 
 306 
5.3. Place a slice anchor made from a U-shaped platinum wire with tightly spaced nylon strings 307 
(“harp”) on the slice to maintain it. 308 
 
  
 
 309 
5.4. Change to a 63x immersion objective and adjust the focus. Check for axons expressing 310 
Chronos-GFP and choose a pyramidal neuron for patch recording. 311 
 312 
5.5. Move the objective upward. 313 
 314 
5.6. Pull pipettes using a Brown-Flaming electrode puller from borosilicate glass. The puller is set 315 
to produce pipettes with approximately 1 μm in tip diameter. Fill the pipettes with K-gluconate-316 
based internal solution.  317 
 318 
5.7. Mount the pipette in the pipette holder on the head-stage. Lower the pipette in the chamber 319 
and find the tip under the objective. Pipette resistance should be between 3–8 MΩ. Apply a light 320 
positive pressure with a syringe so as to see a cone of solution outflow out of the pipette and 321 
progressively lower the pipette and objective to the surface of the slice. 322 
 323 
5.8. Patch the cell in voltage-clamp configuration: approach the identified neuron and delicately 324 
press the pipette tip onto the soma. The positive pressure should produce a dimple on the 325 
membrane surface. Release the pressure to create a giga-ohm seal (>1 GΩ resistance). Once 326 
sealed, set the holding voltage to -65 mV. Break the membrane with a sharp pulse of negative 327 
pressure: this is achieved by applying strong suction to a tube connected to the pipette holder. 328 
 329 
5.9. Record in whole-cell current clamp mode the responses of the neuron to hyperpolarizing and 330 
depolarizing current steps (Figure 2A).  331 
 332 
NOTE: This protocol will be used to determine active and passive intrinsic properties of the cell. 333 
Custom-written MATLAB routines are used for off-line analysis10,16. 334 
 335 
5.10. Record in current- or voltage-clamp postsynaptic responses to whole-field 475 nm LED 336 
stimulation of afferent fibers expressing Chronos. Stimulate with trains of 10 stimulations of 2 337 
ms durations at 20 Hz (Figure 2B,C). Light intensity may vary from 0.1–2 mW.  338 
 339 
NOTE: Light intensity was measured with a digital handheld optical power console equipped with 340 
a photodiode sensor, positioned under the objective. Response latencies of 2–4 ms are 341 
characteristic for a monosynaptic connection. 342 
 343 
5.11. To investigate the nature of the synaptic transmission between the long-range afferents 344 
and the recorded neuron, different pharmacological agents may be used. To pharmacologically 345 
distinguish direct, monosynaptic responses from indirect responses via network activation, add 346 
1 µM TTX and 100 µM 4-AP to the ACSF.  347 
 348 
NOTE: Bath application of glutamate receptor blockers allows to determine the nature of the 349 
neurotransmitter that is released and the identity of postsynaptic receptors. For example, AMPA 350 
type glutamate receptors will be blocked by NBQX (10 µM) and NMDA receptors by APV (100 351 
µM). Depending on the aim of the study, protocols may be conceived to investigate voltage 352 
 
  
 
dependence of synaptic responses or response dynamics over time. 353 
 354 
5.12. Wash with original ACSF solution to patch another cell, or transfer the slice containing a 355 
biocytin-filled neuron in a small vial filled with 4% PFA.  356 
 357 
5.13. After overnight fixation in 4% PFA, wash the slice in 0.1 M PBS (2x for 5 min, 1x for 20 min).  358 
 359 
5.14. Store in 30% sucrose at 4 °C. 360 
  361 
6. Biocytin revelation 362 
 363 
6.1. Transfer the fixed slices containing biocytin-filled neurons onto a glass blade in a drop of 30% 364 
sucrose and perform three cycles of freezing-thawing: place the blade onto dry ice disposed in a 365 
styrofoam box for 1 min until drops of sucrose are completely frozen, then press the blade against 366 
the hand palm to thaw. 367 
 368 
6.2. Wash the slice 3x in 0.1 M PBS (2x for 5 min, 1x for 1 h and 50 min), gently agitated. Do not 369 
exceed 2 h for the last washing. 370 
 371 
6.3. Pre-incubate the slice at RT for 2 h in agitated buffer solution containing 2% milk powder 372 
(0.4 g in 20 mL) to saturate non-specific sites and 0.5% Triton X100 (0.1 mL in 20 mL) to 373 
permeabilize the membranes in 0.1 M PBS. 374 
 375 
6.4. Incubate overnight at 4 °C in a solution containing 2% milk powder, 1% Triton X100, 376 
streptavidin-Cy5 conjugate (1/500), and DAPI (1/1000) in 0.1 M PBS, gently agitated. 377 
 378 
6.5. Wash the slice three times in 0.1 M PBS (2x for 5 min, 1x for 2 h). The last wash can last 379 
longer, up to 4 h, to reduce background staining. 380 
 381 
6.6. Before mounting the slice, use an epifluorescence microscope at 10x magnification 382 
configured to observe Cy5 fluorescent markers in order to identify the side of the slice containing 383 
the marked cell in a chamber filled with PBS. 384 
 385 
6.7. Transfer the slice onto a blade, cell-side up, dry it with a paper tissue, and mount it using 386 
high-resistance mounting medium. 387 
 388 
6.8. Use an epifluorescence microscope at 10x magnification in Cy5 and DAPI configuration to 389 
examine the cell body location, and in GFP configuration to observe the marked afferents, or a 390 
high-resolution confocal microscope at 20x for detailed somatic, axonal, and dendritic 391 
morphology (Figure 2D,E). Filter settings are detailed in the Table of Materials.  392 
 393 
REPRESENTATIVE RESULTS:  394 
The procedure presented here was used to express a blue light-sensitive channelrhodopsin 395 
(Chronos) fused to GFP in the antero-dorsal nucleus of the thalamus (ADN), by stereotaxic 396 
 
  
 
injection of anterograde adeno-associated virus. The stereotaxic coordinates were determined 397 
according to a mouse brain atlas and tested by injecting 200 nL of fluorescent tracer fluoro-ruby. 398 
The animal was sacrificed 10 min after the injection, and the brain was extracted and fixated 399 
overnight. Coronal brain sections were prepared to examine the injection site, which was 400 
correctly placed in and limited to ADN (Figure 1A,B).   401 
 402 
In order to express Chronos-GFP in neurons of ADN, we injected 300 nL of AAV5.Syn.Chronos-403 
GFP.WPRE.bGH. Three weeks after the injection, acute horizontal brain slices were prepared. 404 
Figure 1C shows a brain slice containing the thalamic injection site in the right hemisphere, with 405 
GFP expression in green. Upon inspection with an epi-fluorescence microscope equipped with a 406 
4x objective, GFP labeled thalamic axons were observed in the presubiculum (Figure 1C,D). It was 407 
noted that thalamic axons densely innervated the superficial layers I and III of the presubiculum 408 
(Figure 1D). 409 
 410 
The activity of presubicular neurons in layer III was recorded in the whole-cell patch-clamp 411 
configuration. Hyperpolarizing and depolarizing current steps were applied while recording the 412 
membrane potential variations (Figure 2A). Data was stored on a computer for later offline 413 
analysis of active and passive membrane properties. Presubicular layer III principal cells typically 414 
possessed a negative resting potential close to -63 mV and required depolarizing current 415 
injections to drive the membrane potential to firing threshold. A full description of their intrinsic 416 
properties has been published11. 417 
  418 
Stimulating ADN axon terminals expressing Chronos-GFP elicited excitatory post-synaptic 419 
potentials (EPSPs) in presubicular layer III principal cells in current clamp mode (Figure 2B). 420 
Depending on light intensity, the EPSPs could reach action potential threshold. Postsynaptic 421 
responses were also observed in voltage-clamp mode as excitatory post-synaptic currents 422 
(EPSCs) were elicited (Figure 2C). Onset latencies of EPSCs evoked by light stimulations were 423 
short (median, 1.4 ms10), indicating a direct synaptic contact between thalamic axons and layer 424 
III presubicular neurons. Persisting EPSCs in TTX-4AP condition confirmed this monosynaptic 425 
activation. It is noteworthy that these cells responded reliably to the light stimulations of afferent 426 
axons with a regular firing pattern.  427 
 428 
FIGURE AND TABLE LEGENDS:  429 
 430 
Figure 1: Stereotaxic injection in the anterodorsal thalamic nucleus (ADN). (A) Schematic 431 
representation of the injection. (B) Injection site confirmation with fluoro-ruby in a coronal 432 
section. Inset indicates antero-dorsal level and distance from bregma. (C) Horizontal slice 433 
following AAV-Chronos-GFP injection in the thalamus. The axonal projections to the ipsilateral 434 
presubiculum should be noted. An incision on the left side of the slice (indicated by a black 435 
triangle) marks the contralateral hemisphere. (B, C) Scale bar 1 mm. (D) Magnified view of inset 436 
in (C) with ADN projections to the presubicular superficial layers. Scale bar = 100 µm. 437 
 438 
Figure 2: Presubicular layer III neuron: intrinsic properties, response to light stimulation of 439 
thalamic afferents, and post-hoc revelation of cell morphology. (A) Firing pattern and 440 
 
  
 
membrane potential variations of layer III neuron for hyperpolarizing and depolarizing current 441 
steps. (B, C) Responses of layer III neuron to 2 ms light stimulations (blue bars) of thalamic axons 442 
recorded in (B) current-clamp and (C) voltage-clamp modes. (D, E) Layer III pyramidal neuron 443 
(white, indicated by filled yellow triangle) surrounded by thalamic axons expressing Chronos-GFP 444 
(green) in presubicular superficial layers with DAPI staining (blue) in horizontal slice imaged with 445 
an epifluorescence microscope (D, scale bar = 100 µm) and confocal microscope at a high 446 
magnification (E, scale bar = 50 µm). The cell in (A) is indicated with filled yellow triangles. A 447 
second, partially filled neuron is present in this slice indicated with empty yellow triangles.  448 
 449 
DISCUSSION: 450 
In vivo viral injection to express light-sensitive opsins in a defined brain area is a choice method 451 
for the optogenetic analysis of long-range functional connectivity10,11,17,18. Stereotaxic injections 452 
offer the possibility to precisely target a specific area of the brain. The coexpression of an opsin 453 
with a fluorescent reporter conveniently allows evaluation of the successful expression and 454 
confirmation of the precise injection site. The use of AAV serotype 2/5 typically restricts 455 
expression to the targeted brain region. In this way, a restricted population of neurons is 456 
transfected, expressing light-sensitive ion channels in their cell bodies and axon terminals. In 457 
subsequent ex vivo slice experiments, it is possible to stimulate these axon terminals with light 458 
pulses directly in their target area, while reading out successful synaptic transmission via patch-459 
clamp recording of a post-synaptically connected neuron. The above protocol is robust and 460 
convenient, and some additional notes may help performance of successful experiments.  461 
 462 
Different types of anesthesia may be used. Described here is the intraperitoneal injection of a 463 
ketamine-xylazine combination as an easy-to-use, short-term anesthesia with convenient 464 
analgesia19. The depth and duration of anesthesia may vary to some extent. In some cases, it may 465 
be necessary to inject another half-dose of ketamine-xylazine during the protocol. Isoflurane 466 
anesthesia can be a good alternative to induce more quickly and better control the depth of 467 
anesthesia. Coordinates of injection sites may be determined with the help of a mouse brain 468 
atlas. In practice, coordinates need to be tested and adjusted, if necessary.  469 
 470 
Clean working conditions are also key. It is recommended to use disposable protective gear, 471 
including gloves, a mob cap, and a lab coat. When positioning the animal in the stereotaxic frame, 472 
special attention should be paid to the comfort of the animal, which will greatly improve 473 
efficiency of the anesthesia. The body of the animal should be aligned with the head and neck. 474 
The most critical step in positioning the animal and before craniotomy is adjustment of the 475 
bregma-lambda axis. Especially when targeting deep brain structures, even a small deviation will 476 
generate errors when lowering the injection needle into the brain. In some cases, one may 477 
deliberately choose and calculate an oblique needle trajectory.  478 
 479 
The injection volume is a determinant factor for obtaining precisely localized opsin expression. A 480 
small volume is ideal to privilege a tightly restricted transfection zone. Higher volumes may be 481 
useful to cover the full extent of a large target area. If a large area needs to be covered, such as 482 
the septum18, it may be helpful to place several small injections with a range of neighboring 483 
coordinates. The interval until the ex vivo electrophysiological recording is also critical. A 484 
 
  
 
minimum time for full expression is necessary. While 3 weeks seem to be an optimal delay for 485 
these experiments11, the necessary delay may vary depending on the virus, its serotype, and the 486 
distance to the postsynaptic brain region. 487 
 488 
The approach described here is even more powerful when combined with injections in transgenic 489 
animals. Previous work has exploited different mouse lines for subtypes of GABAergic neurons, 490 
in order to specifically target either PV- or SST-expressing interneurons for patch-clamp 491 
recordings20. Simultaneous double recording of neighboring PV and pyramidal neurons or SST 492 
and pyramidal neurons then allows comparison of strengths of long-range inputs between two 493 
neuron types11. This yields results that are standardized with respect to one neuron type. This 494 
standardization is particularly important in cases where the expression levels of opsins vary 495 
between different animals or different slices.  496 
 497 
Slice health is essential for high-quality patch-clamp recordings. Constant oxygenation of the 498 
slices is crucial, and a slow cutting speed significantly improves slice surface quality. A slice 499 
thickness of 300 µm preserves, to some extent, the microcircuit integrity in horizontal 500 
presubicular sections, including pyramidal neurons with their cell bodies, dendritic and local 501 
axonal ramifications, and local synaptic connections. The type of light-gated channels chosen to 502 
induce activation of afferent fibers will greatly influence the stimulation parameters (duration, 503 
light intensity). Chronos is a blue light-sensitive channelrhodopsin, and a broad range of 504 
illumination wavelengths can be used for activation (peak sensitivity around 500 nm, even with 505 
minimal light intensity of 0.05 mW/mm2, also activated at 405 nm, and up to 530 nm21). 506 
Furthermore, Chronos has fast kinetics properties in comparison to classical ChR2, which enables 507 
high frequency stimulations and reliable activation of long-range projections22. In combination 508 
with the expression of Chrimson, a red-shifted opsin variant, the independent optical excitation 509 
of distinct neural populations becomes feasible. 510 
 511 
ACKNOWLEDGMENTS: 512 
We thank Bertrand Mathon, Mérie Nassar, Li-Wen Huang, and Jean Simonnet for their help in 513 
the development of previous versions of the stereotaxic injection protocol and Marin Manuel 514 
and Patrice Jegouzo for technical help. This work was supported by the French Ministry for 515 
Education and Research (L. R., L. S.), Centre National des Etudes Spatiales (M. B.), and Agence 516 
Nationale de la Recherche Grant “BURST” (D. F.). 517 
 518 
DISCLOSURES: 519 
The authors declare no competing financial interests.  520 
 521 
REFERENCES: 522 
1. Goodridge, J. P., Taube, J. S. Interaction between the postsubiculum and anterior 523 
thalamus in the generation of head direction cell activity. The Journal of Neuroscience: The 524 
Official Journal of the Society for Neuroscience. 17 (23), 9315–9330 (1997). 525 
2. Winter, S. S., Clark, B. J., Taube, J. S. Spatial navigation. Disruption of the head direction 526 
cell network impairs the parahippocampal grid cell signal. Science (New York, N.Y.). 347 (6224), 527 
870–874, doi: 10.1126/science.1259591 (2015). 528 
 
  
 
3. Fan, Y. et al. Activity-dependent decrease of excitability in rat hippocampal neurons 529 
through increases in I(h). Nature Neuroscience. 8 (11), 1542–1551, doi: 10.1038/nn1568 (2005). 530 
4. Takahashi, H., Magee, J. C. Pathway Interactions and Synaptic Plasticity in the Dendritic 531 
Tuft Regions of CA1 Pyramidal Neurons. Neuron. 62 (1), 102–111, doi: 532 
10.1016/j.neuron.2009.03.007 (2009). 533 
5. Dolleman-van der Weel, M. J., Lopes da Silva, F. H., Witter, M. P. Interaction of nucleus 534 
reuniens and entorhinal cortex projections in hippocampal field CA1 of the rat. Brain Structure & 535 
Function. 222 (5), 2421–2438, doi: 10.1007/s00429-016-1350-6 (2017). 536 
6. Callaway, E. M., Yuste, R. Stimulating neurons with light. Current Opinion in Neurobiology. 537 
12 (5), 587–592 (2002). 538 
7. Fino, E. et al. RuBi-Glutamate: Two-Photon and Visible-Light Photoactivation of Neurons 539 
and Dendritic spines. Frontiers in Neural Circuits. 3, 2, doi: 10.3389/neuro.04.002.2009 (2009). 540 
8. Mao, T. et al. Long-range neuronal circuits underlying the interaction between sensory 541 
and motor cortex. Neuron. 72 (1), 111–123, doi: 10.1016/j.neuron.2011.07.029 (2011). 542 
9. Zhang, F. et al. Optogenetic interrogation of neural circuits: technology for probing 543 
mammalian brain structures. Nature Protocols. 5 (3), 439–456, doi: 10.1038/nprot.2009.226 544 
(2010). 545 
10. Simonnet, J. et al. Activity dependent feedback inhibition may maintain head direction 546 
signals in mouse presubiculum. Nature Communications. 8, 16032, doi: 10.1038/ncomms16032 547 
(2017). 548 
11. Nassar, M. et al. Anterior Thalamic Excitation and Feedforward Inhibition of Presubicular 549 
Neurons Projecting to Medial Entorhinal Cortex. Journal of Neuroscience. 38 (28), 6411–6425, 550 
doi: 10.1523/JNEUROSCI.0014-18.2018 (2018). 551 
12. Fricker, D. et al. Pyramidal cells of rodent presubiculum express a tetrodotoxin-insensitive 552 
Na+ current. The Journal of Physiology. 587 (Pt 17), 4249–4264, doi: 553 
10.1113/jphysiol.2009.175349 (2009). 554 
13. Simonnet, J., Eugène, E., Cohen, I., Miles, R., Fricker, D. Cellular neuroanatomy of rat 555 
presubiculum. The European Journal of Neuroscience. 37 (4), 583–597, doi: 10.1111/ejn.12065 556 
(2013). 557 
14. Simonnet, J., Fricker, D. Cellular components and circuitry of the presubiculum and its 558 
functional role in the head direction system. Cell and Tissue Research. 373 (3), 541–556, doi: 559 
10.1007/s00441-018-2841-y (2018). 560 
15. Paxinos, G., Franklin, K. B. J. The Mouse Brain in Stereotaxic Coordinates. Academic: New 561 
York. (2013). 562 
16. Huang, L.-W. et al. Laminar Localization and Projection-Specific Properties of Presubicular 563 
Neurons Targeting the Lateral Mammillary Nucleus, Thalamus, or Medial Entorhinal Cortex. 564 
eNeuro. 4 (2), doi: 10.1523/ENEURO.0370-16.2017 (2017). 565 
17. Cruikshank, S. J., Urabe, H., Nurmikko, A. V., Connors, B. W. Pathway-specific feedforward 566 
circuits between thalamus and neocortex revealed by selective optical stimulation of axons. 567 
Neuron. 65 (2), 230–245, doi: 10.1016/j.neuron.2009.12.025 (2010). 568 
18. Gonzalez-Sulser, A. et al. GABAergic Projections from the Medial Septum Selectively 569 
Inhibit Interneurons in the Medial Entorhinal Cortex. Journal of Neuroscience. 34 (50), 16739–570 
16743, doi: 10.1523/JNEUROSCI.1612-14.2014 (2014). 571 
19. Mathon, B. et al. Increasing the effectiveness of intracerebral injections in adult and 572 
 
  
 
neonatal mice: a neurosurgical point of view. Neuroscience Bulletin. 31 (6), 685–696, doi: 573 
10.1007/s12264-015-1558-0 (2015). 574 
20. Nassar, M. et al. Diversity and overlap of parvalbumin and somatostatin expressing 575 
interneurons in mouse presubiculum. Frontiers in Neural Circuits. 9, 20, doi: 576 
10.3389/fncir.2015.00020 (2015). 577 
21. Klapoetke, N. C. et al. Independent optical excitation of distinct neural populations. 578 
Nature Methods. 11 (3), 338–346, doi: 10.1038/nmeth.2836 (2014). 579 
22. Hass, C. A., Glickfeld, L. L. High-fidelity optical excitation of cortico-cortical projections at 580 
physiological frequencies. Journal of Neurophysiology. 116 (5), 2056–2066, doi: 581 
10.1152/jn.00456.2016 (2016). 582 
 583 
 584 
 585 
Figure 1. 586 
 587 
 
  
 
Figure 2. 588 
 589 
 590 
